BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 6718723)

  • 1. Tumoral calcinosis, diaphysitis, and hyperphosphatemia.
    Clarke E; Swischuk LE; Hayden CK
    Radiology; 1984 Jun; 151(3):643-6. PubMed ID: 6718723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diaphysitis in tumoral calcinosis syndrome.
    Ballina-García FJ; Queiro-Silva R; Fernández-Vega F; Fernández-Sánchez JA; Weruaga-Rey A; Pérez-Del Rio MJ; Rodríguez-Pérez A
    J Rheumatol; 1996 Dec; 23(12):2148-51. PubMed ID: 8970054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumoral calcinosis with hyperphosphatemia. A report of a family with incidence in four siblings.
    Baldursson H; Evans EB; Dodge WF; Jackson WT
    J Bone Joint Surg Am; 1969 Jul; 51(5):913-25. PubMed ID: 5793850
    [No Abstract]   [Full Text] [Related]  

  • 4. Hyperphosphatemic familial tumoral calcinosis mimicking a cystic hemo-lymphangioma on MRI.
    Houss SE; LRhorfi N; Yousfi ZE; Haddad SE; Chat L; Allali N; Rguieg N; Lamalmi N
    Radiol Case Rep; 2022 Dec; 17(12):4603-4607. PubMed ID: 36193273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical variability of familial tumoral calcinosis caused by novel GALNT3 mutations.
    Ichikawa S; Baujat G; Seyahi A; Garoufali AG; Imel EA; Padgett LR; Austin AM; Sorenson AH; Pejin Z; Topouchian V; Quartier P; Cormier-Daire V; Dechaux M; Malandrinou FCh; Singhellakis PN; Le Merrer M; Econs MJ
    Am J Med Genet A; 2010 Apr; 152A(4):896-903. PubMed ID: 20358599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrent primary hyperphosphatemic tumoral calcinosis: a case report.
    Rangaswamy M; Jayashree K; Saggam P; Vimala MG
    Acta Cytol; 2010; 54(5 Suppl):1003-6. PubMed ID: 21053587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperphosphatemic tumoral calcinosis: a 10-year follow-up.
    Alves C; Lima R
    J Pediatr Endocrinol Metab; 2011; 24(1-2):25-7. PubMed ID: 21528811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tumoral calcinosis. Apropos of 2 cases seen at Shaba, Zaire Republic].
    Jacquerye L; Kalengayi M; Baudry A; Parmentier R
    Ann Soc Belg Med Trop; 1974; 54(3):209-16. PubMed ID: 4842679
    [No Abstract]   [Full Text] [Related]  

  • 9. Autoimmune hyperphosphatemic tumoral calcinosis in a patient with FGF23 autoantibodies.
    Roberts MS; Burbelo PD; Egli-Spichtig D; Perwad F; Romero CJ; Ichikawa S; Farrow E; Econs MJ; Guthrie LC; Collins MT; Gafni RI
    J Clin Invest; 2018 Dec; 128(12):5368-5373. PubMed ID: 30226830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary hyperphosphatemic tumoral calcinosis: a case report.
    Huang J; Cao LG; Zhang TR; Li SM; Meng QQ
    Osteoporos Int; 2022 Jan; 33(1):309-312. PubMed ID: 34245344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Newly discovered mutations in the GALNT3 gene causing autosomal recessive hyperostosis-hyperphosphatemia syndrome.
    Gok F; Chefetz I; Indelman M; Kocaoglu M; Sprecher E
    Acta Orthop; 2009 Feb; 80(1):131-4. PubMed ID: 19297793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumoral calcinosis. A report of six cases.
    Harkess JW; Peters HJ
    J Bone Joint Surg Am; 1967 Jun; 49(4):721-31. PubMed ID: 6026005
    [No Abstract]   [Full Text] [Related]  

  • 13. Hyperphosphatemic familial tumoral calcinosis secondary to fibroblast growth factor 23 (FGF23) mutation: a report of two affected families and review of the literature.
    Chakhtoura M; Ramnitz MS; Khoury N; Nemer G; Shabb N; Abchee A; Berberi A; Hourani M; Collins M; Ichikawa S; El Hajj Fuleihan G
    Osteoporos Int; 2018 Sep; 29(9):1987-2009. PubMed ID: 29923062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recessive mutation in GALNT3 causes hyperphosphatemic familial tumoral calcinosis associated with chronic recurrent multifocal osteomyelitis.
    Albaramki J; Dmour H; Shboul M; Bonnard C; Venkatesh B; Odeh R
    Turk J Pediatr; 2019; 61(1):130-133. PubMed ID: 31559735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperphosphatemic Familial Tumoral Calcinosis in Two Siblings with a Novel Mutation in
    Kışla Ekinci RM; Gürbüz F; Balcı S; Bişgin A; Taştan M; Yüksel B; Yılmaz M
    J Clin Res Pediatr Endocrinol; 2019 Feb; 11(1):94-99. PubMed ID: 30015621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tumor calcinosis. Review of the literature: apropos of a case].
    Haddad SN; Ghossain MA; Jebara VA; Roucos S; Kharrat K; Boustany FN
    Rev Chir Orthop Reparatrice Appar Mot; 1989; 75(5):340-4. PubMed ID: 2682818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorus excretion in tumoral calcinosis: response to parathyroid hormone and acetazolamide.
    Lufkin EG; Wilson DM; Smith LH; Bill NJ; DeLuca HF; Dousa TP; Knox FG
    J Clin Endocrinol Metab; 1980 Apr; 50(4):648-53. PubMed ID: 7364922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumoral calcinosis.
    Berkowitz ST; Green OC; Young LW
    Am J Dis Child; 1986 Dec; 140(12):1273-5. PubMed ID: 3776945
    [No Abstract]   [Full Text] [Related]  

  • 19. Tumoral calcinosis of the ischium.
    Krueger-Franke M; Siebert CH; Weiss M; Rosemeyer B; Gokel M
    Arch Orthop Trauma Surg; 1992; 111(5):284-6. PubMed ID: 1389783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperphosphataemic tumoral calcinosis in Bedouin Arabs--clinical and radiological features.
    McGuinness FE
    Clin Radiol; 1995 Apr; 50(4):259-64. PubMed ID: 7729126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.